Patients were stratified by hypogonadal status and randomly assigned in a 2 : 1 ratio to receive oral alendronic acid 70mg once-weekly tablets or placebo using a computer-generated, blinded ...

Until now, the main options for women in this category have been UCB's Evenity (romosozumab) or Eli Lilly's Forsteo (teriparatide), with older generic bisphosphonates such as alendronic acid used ...